Question 1

What is the catalog number for 3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide?

Accepted Answer

The catalog number for 3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide is sc-493079.

Question 2

What sizes are available for 3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide?

Accepted Answer

3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide is available in the following size(s): 5 mg.

Question 3

Is 3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide in stock?

Accepted Answer

3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

3-Chloro-4-fluoro-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide

Product Specifications

Frequently Asked Questions

Explore Other Products

TCF4 (Transcription Factor 4) (TCF4/1705), CF568 conjugate, 0.1mg/mL

Anti-MCP3/CCL7 Antibody Picoband®

Cyclin B2 (X29.2), CF740 conjugate, 0.1mg/mL

MUC2 (CCP58), CF740 conjugate, 0.1mg/mL

Bcl-2 (BCL2/782), CF405S conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, 0.1mg/mL